Lupin : discovery research /
Lupin, an India-based pharma firm, started its Novel Drug Discovery and Development (NDDD) division in 2010, for which it built infrastructure from scratch. In 2018, Lupin's NDDD successfully licensed MALT1 inhibitors to AbbVie, a multinational pharma firm, for a down payment of USD 30 million...
Full description
Bibliographic Details
| Main Authors: |
Sahay, Arvind
(Author),
Tiwari, Tara
(Author),
Kamboj, Raj
(Author),
Vēṅkaṭa Subbārāvu, Paḷḷe
(Author),
Sharma, Sharad (Sharad K.)
(Author) |
|---|
| Format: | eBook
|
|---|
| Language: | English |
|---|
| Published: |
London :
Indian Institute of Management, Ahmedabad,
2020.
|
|---|
| Series: | SAGE business cases.
|
|---|
| Subjects: | |
|---|
| Online Access: | Connect to the full text of this electronic book
|
|---|